COMMUNITY HEALTH SYSTEMS INC CYH

Healthcare SIC 8062 - Services-General Medical & Surgical Hospitals, NEC NAICS Health Care and Social Assistance › Hospitals › General Medical and Surgical Hospitals derived NYSE

We are one of the nation's largest healthcare companies. Our affiliates are leading providers of healthcare services, developing and operating healthcare delivery systems in 36 distinct markets across 14 states. At December 31, 2025, our subsidiaries own or lease 69 affiliated hospitals, with more than 10,000 beds, and operate more than 1,000 sites of care, including physician practices, urgent care centers, freestanding emergency departments, occupational medicine clinics, imaging centers, cancer centers and ambulatory surgery centers. We generate revenues by providing a broad range of general and specialized hospital healthcare services and outpatient services to patients in the communities in which we are located. For the hospitals and other sites of care that we own and operate, we are paid for our services by governmental agencies, private insurers and directly by the patients we serve. Services provided through our hospitals and outpatient facilities include general acute care, emergency room, general and specialty surgery, critical care, internal medicine, obstetrics, diagnostic, psychiatric and rehabilitation services. An integral part of providing these services is our network of affiliated physicians at our hospitals and affiliated businesses. At December 31, 2025, we employed approximately 1,700 physicians and an additional 1,400 licensed healthcare practitioners. Through our management and operation of these businesses, we provide standardization and centralization of operations across key business areas; strategic assistance to expand and improve services and facilities; implementation of patient safety and quality of care improvement programs and assistance in the recruitment of additional physicians and licensed healthcare practitioners to the markets in which our hospitals are located. In a number of our markets, we have partnered with local physicians, for-profit entities and/or not-for-profit providers in the ownership of our facilities.

Last close 2.92 2026-10-23
Market cap $411.7M 2026-06-30 share count
52-week range 2.40 - 4.43

Valuation FY2025 figures against the last close

P/S0.0x
P/E0.8x
P/FCF2.0x
EV/EBITDA7.1x
Dividend yield—
Diluted EPS3.77

Annual financial statements

Income statement

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue $12.48B$12.63B$12.49B$12.21B$12.37B$11.79B$13.21B$14.15B$15.35B$18.44B
Cost of revenue $1.86B$1.95B$1.99B$1.98B$2.04B$1.96B$2.15B$2.35B$2.67B$3.01B
Gross profit $10.62B$10.69B$10.50B$10.24B$10.33B$9.83B$11.06B$11.80B$12.68B$15.43B
Total operating expenses $11.00B$12.09B$11.53B$11.39B$10.97B$10.66B$12.56B$13.95B$17.23B$19.30B
Operating income $1.49B$542.0M$957.0M$821.0M$1.40B$1.13B$650.0M$208.0M-$1.88B-$860.0M
Pre-tax income $724.0M-$283.0M$207.0M$349.0M$499.0M$422.0M-$430.0M-$715.0M-$2.83B-$1.72B
Income tax $48.0M$79.0M$191.0M$170.0M$131.0M$185.0M$160.0M$11.0M$449.0M$104.0M
Net income $509.0M-$516.0M-$133.0M$46.0M$230.0M$511.0M-$675.0M-$788.0M-$2.46B-$1.72B
EPS, basic 3.81-3.90-1.020.351.824.43-5.93-6.99-22.00-15.54
EPS, diluted 3.77-3.90-1.020.351.764.39-5.93-6.99-22.00-15.54
Shares, diluted (wtd. avg.) 135.0M132.1M130.4M130.1M130.6M116.5M113.7M112.7M111.8M110.7M

Balance sheet

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents $260.0M$37.0M$38.0M$118.0M$507.0M$1.68B$216.0M$196.0M$563.0M$238.0M
Receivables $2.08B$2.29B$2.23B$2.04B$2.06B$1.93B$2.26B$2.35B$2.38B$3.18B
Total current assets $3.23B$3.30B$3.21B$3.08B$3.48B$4.51B$3.43B$3.55B$4.07B$4.67B
Property, plant and equipment $4.50B$4.78B$5.21B$5.37B$5.55B$5.32B$5.61B$6.14B$7.05B$8.15B
Goodwill $3.32B$3.79B$3.96B$4.17B$4.22B$4.22B$4.33B$4.56B$4.72B$6.52B
Other intangibles $7.0M$15.0M$20.0M$2.0M————$10.0M$14.0M
Total assets $13.20B$14.05B$14.46B$14.67B$15.22B$16.01B$15.61B$15.86B$17.45B$21.94B
Accounts payable $842.0M$913.0M$912.0M$773.0M$830.0M$783.0M$811.0M$887.0M$967.0M$995.0M
Total current liabilities $2.21B$2.35B$2.14B$2.19B$2.36B$2.81B$2.28B$2.39B$2.36B$2.89B
Long-term debt $10.38B$11.43B$11.47B$11.61B$12.11B$12.09B$13.38B$13.39B$13.91B$15.24B
Total liabilities $14.04B$15.37B$15.28B$15.40B$16.03B$17.06B$17.25B$16.82B$17.61B$19.66B
Retained earnings -$3.57B-$4.08B-$3.56B-$3.43B-$3.48B-$3.71B-$4.22B-$3.54B-$2.76B-$299.0M
Total equity -$1.39B-$1.91B-$1.15B-$1.27B-$1.29B-$1.54B-$2.14B-$1.46B-$692.0M$1.73B

Cash flow

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Operating cash flow $543.0M$480.0M$210.0M$300.0M-$131.0M$2.18B$385.0M$274.0M$773.0M$1.14B
Depreciation and amortisation ——————$608.0M$700.0M$861.0M$1.10B
Stock-based compensation $11.0M$17.0M$22.0M$20.0M$25.0M$13.0M$10.0M$13.0M$24.0M$46.0M
Capital expenditure $335.0M$360.0M$467.0M$415.0M$469.0M$440.0M$438.0M$527.0M$564.0M$744.0M
Investing cash flow $847.0M-$275.0M-$26.0M-$259.0M-$524.0M$177.0M-$2.0M-$245.0M$1.07B$630.0M
Financing cash flow -$1.17B-$206.0M-$264.0M-$430.0M-$514.0M-$895.0M-$363.0M-$396.0M-$1.52B-$1.71B

Figures as tagged in each year's own filing, in US dollars. A year restated by a later filing shows the restated figure. Capital expenditure, dividends and buybacks are cash out, shown positive. A line the filer does not report is not listed. Latest from accession 0001193125-26-059509.

Plot the figures US dollars

Income statement Revenue Cost of revenue Gross profit R&D SG&A Total operating expenses Operating income Interest expense Pre-tax income Income tax Net income EPS, basic EPS, diluted Shares, diluted (wtd. avg.)
Balance sheet Cash and equivalents Short-term investments Receivables Inventory Total current assets Property, plant and equipment Goodwill Other intangibles Total assets Accounts payable Short-term debt Total current liabilities Long-term debt Total liabilities Retained earnings Total equity
Cash flow Operating cash flow Depreciation and amortisation Stock-based compensation Capital expenditure Investing cash flow Financing cash flow Dividends paid Buybacks
  • Revenue
  • Gross profit
  • Net income
Revenue, Gross profit, Net income by fiscal year, in US dollars The same figures are in the table below this chart. -10B 0 10B 20B Revenue, FY2016: 18.4B Gross profit, FY2016: 15.4B Net income, FY2016: -1.7B Revenue, FY2017: 15.4B Gross profit, FY2017: 12.7B Net income, FY2017: -2.5B Revenue, FY2018: 14.2B Gross profit, FY2018: 11.8B Net income, FY2018: -788M Revenue, FY2019: 13.2B Gross profit, FY2019: 11.1B Net income, FY2019: -675M Revenue, FY2020: 11.8B Gross profit, FY2020: 9.8B Net income, FY2020: 511M Revenue, FY2021: 12.4B Gross profit, FY2021: 10.3B Net income, FY2021: 230M Revenue, FY2022: 12.2B Gross profit, FY2022: 10.2B Net income, FY2022: 46M Revenue, FY2023: 12.5B Gross profit, FY2023: 10.5B Net income, FY2023: -133M Revenue, FY2024: 12.6B Gross profit, FY2024: 10.7B Net income, FY2024: -516M Revenue, FY2025: 12.5B Gross profit, FY2025: 10.6B Net income, FY2025: 509M FY2016 FY2017 FY2018 FY2019 FY2020 FY2021 FY2022 FY2023 FY2024 FY2025
Fiscal year FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue $18.44B $15.35B $14.15B $13.21B $11.79B $12.37B $12.21B $12.49B $12.63B $12.48B
Gross profit $15.43B $12.68B $11.80B $11.06B $9.83B $10.33B $10.24B $10.50B $10.69B $10.62B
Net income -$1.72B -$2.46B -$788.0M -$675.0M $511.0M $230.0M $46.0M -$133.0M -$516.0M $509.0M

Recent filings and events

  • Results announced The quarterly or annual earnings release. Arrives four times a year from almost every company here. Item 2.02
  • Regulation FD disclosure Something the company told the market and had to tell everyone at once - usually a slide deck or a press release. Item 7.01
  • Acquisition or disposal completed A purchase or sale of a significant business or asset has closed. Item 2.01
  • Other event The catch-all. The company chose to disclose something that fits no other item, so the content is whatever it says it is. Item 8.01
  • Shareholder vote The results of the annual meeting or a special vote. Item 5.07
  • Other event Item 8.01
  • Other event Item 8.01
  • Results announced Item 2.02
  • Regulation FD disclosure Item 7.01
  • Acquisition or disposal completed Item 2.01
  • Other event Item 8.01
  • Material agreement signed The company entered an agreement outside the ordinary course of business - a large contract, a credit facility, a merger agreement. Item 1.01

Item numbers are Form 8-K's own, and a filing date is up to four business days after the thing it reports. The same feed across the whole market.

Others in SIC 8062

TickerCompanyMarket capP/ERevenue growth
HCA HCA Healthcare, Inc. $104.05B 16.6x 7.1%
THC TENET HEALTHCARE CORP $21.62B 17.3x 3.1%
UHS UNIVERSAL HEALTH SERVICES INC $11.15B 8.1x 9.7%
SGRY Surgery Partners, Inc. $2.06B — 6.2%
ARDT Ardent Health, Inc. $1.73B 12.8x 6.0%